The Asian population is thought to have a low risk of venous thromboembolism (VTE), but
the epidemiology of VTE in cancer patients remains unclear. The National Health Insurance …

Background Venous thromboembolism (VTE) is a clinically significant complication that is
well documented among Caucasian cancer patients. However, evidence regarding VTE …

Cancer patients with venous thromboembolism (VTE) are prone to poor prognoses. Thus,
we aimed to develop a nomogram to predict the risk of VTE in these patients. We …

Venous thromboembolism (VTE) is common in cancer patients, and is associated with
significant morbidity and mortality. Several factors, including procoagulant agents secreted …

Cancer patients are at increased risk of developing venous thromboembolism (VTE).
Guidelines recommend routine thromboprophylaxis in hospitalised acutely ill cancer …

The risk of venous thromboembolism (VTE) is elevated in cancer, and thrombosis is the
second leading cause of death in patients with malignancy. Many risk factors for cancer …

Background Current risk assessment models (RAMs) for prediction of venous
thromboembolism (VTE) risk in the outpatient cancer population have shown poor predictive …

Introduction The objective of this study was to examine the differences in commonly
associated characteristics and risk factors of venous thromboembolism (VTE) between …

Background. Retrospective studies have suggested an association between cancer-
associated venous thromboembolism (VTE) and patient survival. We evaluated a previously …

Retrospective population-based studies showed that in cancer patients venous
thromboembolism (VTE) is associated with reduced survival. Master Oncology is a …